Journal of Advanced Biotechnology and Experimental Therapeutics (Apr 2022)

Prevalence of hyperlipidemia in controlled and uncontrolled type-2 diabetic patients

  • Mohammad Abul Hasnat,
  • Farhan Rahman Niloy,
  • Arafat Islam Ashik,
  • Mahedi Hasan,
  • Preonath Chondrow Dev,
  • Sharmin Sultana Panna,
  • Md. Waseque Mia,
  • Zafrul Hasan

DOI
https://doi.org/10.5455/jabet.2022.d112
Journal volume & issue
Vol. 5, no. 1
pp. 247 – 256

Abstract

Read online

Patients with type-2 diabetes mellitus (T2DM) are known to suffer from hyperlipidemia. How hyperlipidemia is associated with controlled and uncontrolled T2DM patients in Bangladesh remained to be addressed. In this cross-sectional study, 211 participants were enrolled who have been suffering from T2DM for more than 4 years from the northeastern part of Bangladesh. Controlled and uncontrolled patients were defined with their plasma glycated hemoglobin (HbA1c) levels. Among them, 39% and 61% were in the diabetic-controlled and uncontrolled groups. Indeed, the diabetic uncontrolled group showed a higher frequency of hypercholesterolemia, hypertriglyceridemia, hyper LDL-cholesterolemia, and hypo HDL-cholesterolemia compare to the diabetic controlled group. Lipid profiling analysis revealed significantly elevated (p [ J Adv Biotechnol Exp Ther 2022; 5(1.000): 247-256]

Keywords